Male cancer survivors fail to monitor fertility post-treatment | Report: Patient navigators can help improve quality of care | Cancer survivor discusses experience of "chemo-feet"
Web Version
 
 
January 10, 2013
CONNECT WITH LIVESTRONG  FacebookTwitterPinterestFlickrYouTube
LIVESTRONG
Cancer news and resources for health care professionals
SIGN UP|FORWARD|ARCHIVE

Patient-Centered Cancer Care
Male cancer survivors fail to monitor fertility post-treatment
A survey found 35.8% of male cancer survivors never attended a follow-up appointment to evaluate their fertility after undergoing cancer treatment and banking their sperm, according to a U.K. study presented at Fertility 2013. "Our research suggests that there is a need to educate men about the benefits of attending follow-up fertility clinics and the long-term consequences of non-attendance," lead researcher Allan Pacey said. DoctorsLounge.com (1/7)
Share: LinkedIn Twitter Facebook Google+ Email
Report: Patient navigators can help improve quality of care
Deploying patient navigators, who guide patients through the system and help them overcome health care barriers, may lead to better medical outcomes and patient satisfaction while cutting no-show rates and care disparities, according to a report by the Center for Health Affairs. BeckersHospitalReview.com (1/3)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
Emerging Trends, Products & Technologies
Oncologists want more collaboration with primary care doctors
The American Society of Clinical Oncology said it would issue guidelines to help primary care physicians become more involved in the long-term care of cancer survivors. The group suggested a shared-care model that would have primary care physicians collaborate with oncologists and provide noncancer care. MedPage Today (free registration) (1/4)
Share: LinkedIn Twitter Facebook Google+ Email
E-mail alerts remind docs to have end-of-life talks with patients
E-mail reminders could prompt oncologists to have end-of-life conversations with patients who are terminally ill, according to a study in the Journal of Clinical Oncology. The study, which involved 100 patients with an advanced stage of lung cancer, found that one year after a system was launched to send e-mail alerts to doctors, more than one-third of the subjects had their end-of-life wishes noted in their EHRs, compared with 15% of patients whose end-of-life wishes were recorded before the e-mail program began. Reuters (1/3)
Share: LinkedIn Twitter Facebook Google+ Email
Cancer Research & Health Policy
Report finds continued decline of cancer deaths in U.S.
Cancer mortality rates among men, women and children up to age 14 dropped every year from 2000 to 2009, continuing the downward trend that started in the 1990s, a report in the Journal of the National Cancer Institute showed. New cancer diagnoses dropped in men and remained unchanged in women, but pediatric cancer diagnoses rose by 0.6% during the study period. WebMD (1/7), HealthDay News (1/7)
Share: LinkedIn Twitter Facebook Google+ Email
Health officials aim to cut cancer rates in New York
Health officials are aiming to lower cancer rates in New York, where an estimated 288 people are diagnosed with cancer daily. Among the preventive measures included in a five-year plan are greater access to quality cancer therapy and increased awareness of and access to cancer screenings. United Press International (1/6)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
Foundation News
Cancer Survivors and Clinical Trials
I had no idea what melanoma was. I found out the cancer had spread to my lungs, chest and back. The oncologist said it was a “very mean melanoma.” I didn’t have health insurance, and I didn’t know anything about clinical trials. What I’ve learned is that it’s absolutely crucial to have access to information. Now I know that all the drugs and medicines we take every day were subject to clinical trials and developmental studies. Learn more about Brian’s story at LIVESTRONG.org/Brian.
Share: LinkedIn Twitter Facebook Google+ Email
A Glimpse into the Future of Cancer Therapy
The Cancer Genome Atlas Project is a major cancer initiative to help health care professionals better understand precisely what is “broken” in their patients. To borrow a car metaphor, if a cancer patient needs a new timing belt, they will get the timing belt that is manufactured specifically for their make and model. The fix may still be easy or complicated, but knowing precisely what’s broken leads to the best options for considering repair. Read more about the comprehensive work in the mechanics of cancer on the LIVESTRONG blog.
Share: LinkedIn Twitter Facebook Google+ Email
LIVESTRONG SmartQuote
I deal with my fear of recurrence by getting involved. I am involved with a group of young breast cancer survivors, and I try to be there for newly diagnosed people."
-- Audra O., cancer survivor
Share: LinkedIn Twitter Facebook Google+ Email
Learn more about LIVESTRONG ->Homepage
The LIVESTRONG Foundation does not necessarily endorse the opinions that may be mentioned on this site, the articles are published for informational purposes and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this site.
About the LIVESTRONG Foundation
The LIVESTRONG Foundation provides free cancer support services to help people cope with the financial, emotional and practical challenges that accompany the disease. Created in 1997 by cancer survivor and philanthropist Lance Armstrong, the Foundation is known for its powerful brand – LIVESTRONG–and for its advocacy on behalf of survivors and their families. With its iconic yellow LIVESTRONG wristband, the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has raised nearly $500 million to support cancer survivors and served 2.5 million people affected by the disease. For more information, visit LIVESTRONG.org.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information